Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Using marginal structural models to adjust for treatment drop-in when developing clinical prediction models.

Sperrin M, Martin GP, Pate A, Van Staa T, Peek N, Buchan I.

Stat Med. 2018 Aug 2. doi: 10.1002/sim.7913. [Epub ahead of print]

PMID:
30073700
2.

Association of comorbid burden with clinical outcomes after transcatheter aortic valve implantation.

Bagur R, Martin GP, Nombela-Franco L, Doshi SN, George S, Toggweiler S, Sponga S, Cotton JM, Khogali SS, Ratib K, Kinnaird T, Anderson RA, Chu MWA, Kiaii B, Biagioni C, Schofield-Kelly L, Loretz L, Torracchi L, Sekar B, Kwok CS, Sperrin M, Ludman PF, Mamas MA.

Heart. 2018 Jul 20. pii: heartjnl-2018-313356. doi: 10.1136/heartjnl-2018-313356. [Epub ahead of print]

PMID:
30030336
3.

Crystallisation of freeze-dried sucrose in model mixtures that represent the amorphous sugar matrices present in confectionery.

Jawad R, Elleman C, Martin GP, Royall PG.

Food Funct. 2018 Jul 20. doi: 10.1039/c8fo00729b. [Epub ahead of print]

PMID:
30027968
4.

Do frailty measures improve prediction of mortality and morbidity following transcatheter aortic valve implantation? An analysis of the UK TAVI registry.

Martin GP, Sperrin M, Ludman PF, deBelder MA, Gunning M, Townend J, Redwood SR, Kadam UT, Buchan I, Mamas MA.

BMJ Open. 2018 Jun 30;8(6):e022543. doi: 10.1136/bmjopen-2018-022543.

5.

How the Availability of Observation Status Affects Emergency Physician Decisionmaking.

Wright B, Martin GP, Ahmed A, Banerjee J, Mason S, Roland D.

Ann Emerg Med. 2018 Jun 4. pii: S0196-0644(18)30369-X. doi: 10.1016/j.annemergmed.2018.04.023. [Epub ahead of print]

PMID:
29880439
6.

Making soft intelligence hard: a multi-site qualitative study of challenges relating to voice about safety concerns.

Martin GP, Aveling EL, Campbell A, Tarrant C, Pronovost PJ, Mitchell I, Dankers C, Bates D, Dixon-Woods M.

BMJ Qual Saf. 2018 Sep;27(9):710-717. doi: 10.1136/bmjqs-2017-007579. Epub 2018 Feb 19.

7.

A multiple-model generalisation of updating clinical prediction models.

Martin GP, Mamas MA, Peek N, Buchan I, Sperrin M.

Stat Med. 2018 Apr 15;37(8):1343-1358. doi: 10.1002/sim.7586. Epub 2017 Dec 18.

8.

Novel United Kingdom prognostic model for 30-day mortality following transcatheter aortic valve implantation.

Martin GP, Sperrin M, Ludman PF, de Belder MA, Redwood SR, Townend JN, Gunning M, Moat NE, Banning AP, Buchan I, Mamas MA.

Heart. 2018 Jul;104(13):1109-1116. doi: 10.1136/heartjnl-2017-312489. Epub 2017 Dec 7.

9.

Relative Survival After Transcatheter Aortic Valve Implantation: How Do Patients Undergoing Transcatheter Aortic Valve Implantation Fare Relative to the General Population?

Martin GP, Sperrin M, Hulme W, Ludman PF, de Belder MA, Toff WD, Alabas O, Moat NE, Doshi SN, Buchan I, Deanfield JE, Gale CP, Mamas MA; National Institute of Cardiovascular Outcomes Research (NICOR).

J Am Heart Assoc. 2017 Oct 17;6(10). pii: e007229. doi: 10.1161/JAHA.117.007229.

10.

Effect of weekend admission on process of care and clinical outcomes for the management of acute coronary syndromes: a retrospective analysis of three UK centres.

Martin GP, Kinnaird T, Sperrin M, Anderson R, Gamal A, Jabbar A, Kwok CS, Barker D, Heatlie G, Zaman AG, Mamas MA.

BMJ Open. 2017 Sep 29;7(9):e016866. doi: 10.1136/bmjopen-2017-016866.

11.

Major health service transformation and the public voice: conflict, challenge or complicity?

Martin GP, Carter P, Dent M.

J Health Serv Res Policy. 2018 Jan;23(1):28-35. doi: 10.1177/1355819617728530. Epub 2017 Sep 4.

12.

The personal and the organisational perspective on iatrogenic harm: bridging the gap through reconciliation processes.

Martin GP, Chew S, Palser TR.

BMJ Qual Saf. 2017 Oct;26(10):779-781. doi: 10.1136/bmjqs-2017-006914. Epub 2017 Jul 26. No abstract available.

PMID:
28747324
13.

Informatics for Health 2017: Advancing both science and practice.

Scott PJ, Cornet R, McCowan C, Peek N, Fraccaro P, Geifman N, Gude WT, Hulme W, Martin GP, Williams R.

J Innov Health Inform. 2017 Apr 21;24(1):1-185. doi: 10.14236/jhi.v24i1.939.

14.

Pathways to professionalism? Quality improvement, care pathways, and the interplay of standardisation and clinical autonomy.

Martin GP, Kocman D, Stephens T, Peden CJ, Pearse RM; This study was carried out as part of a wider randomised controlled trial, EPOCH.

Sociol Health Illn. 2017 Nov;39(8):1314-1329. doi: 10.1111/1467-9566.12585. Epub 2017 Jun 21.

PMID:
28639296
15.

Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation.

Martin GP, Sperrin M, Ludman PF, de Belder MA, Gale CP, Toff WD, Moat NE, Trivedi U, Buchan I, Mamas MA.

Am Heart J. 2017 Feb;184:97-105. doi: 10.1016/j.ahj.2016.10.020. Epub 2016 Nov 3.

16.

Pre-Implantation Balloon Aortic Valvuloplasty and Clinical Outcomes Following Transcatheter Aortic Valve Implantation: A Propensity Score Analysis of the UK Registry.

Martin GP, Sperrin M, Bagur R, de Belder MA, Buchan I, Gunning M, Ludman PF, Mamas MA.

J Am Heart Assoc. 2017 Feb 18;6(2). pii: e004695. doi: 10.1161/JAHA.116.004695.

17.

Clinical prediction in defined populations: a simulation study investigating when and how to aggregate existing models.

Martin GP, Mamas MA, Peek N, Buchan I, Sperrin M.

BMC Med Res Methodol. 2017 Jan 6;17(1):1. doi: 10.1186/s12874-016-0277-1.

18.

Use or Abuse? A Qualitative Study of Emergency Physicians' Views on Use of Observation Stays at Three Hospitals in the United States and England.

Martin GP, Wright B, Ahmed A, Banerjee J, Mason S, Roland D.

Ann Emerg Med. 2017 Mar;69(3):284-292.e2. doi: 10.1016/j.annemergmed.2016.08.458. Epub 2016 Nov 23.

19.

The development of a growth regime map for a novel reverse-phase wet granulation process.

Wade JB, Martin GP, Long DF.

Int J Pharm. 2016 Oct 15;512(1):224-233. doi: 10.1016/j.ijpharm.2016.08.050. Epub 2016 Aug 26.

PMID:
27568497
20.

In vivo pharmacological activity and biodistribution of S-nitrosophytochelatins after intravenous and intranasal administration in mice.

Heikal L, Starr A, Martin GP, Nandi M, Dailey LA.

Nitric Oxide. 2016 Sep 30;59:1-9. doi: 10.1016/j.niox.2016.06.006. Epub 2016 Jun 24.

21.

Establishing the importance of oil-membrane interactions on the transmembrane diffusion of physicochemically diverse compounds.

Najib ON, Martin GP, Kirton SB, Sallam AS, Murnane D.

Int J Pharm. 2016 Jun 15;506(1-2):429-37. doi: 10.1016/j.ijpharm.2016.03.020. Epub 2016 Mar 21.

PMID:
27012979
22.

The Safer Delivery of Surgical Services Program (S3): Explaining Its Differential Effectiveness and Exploring Implications for Improving Quality in Complex Systems.

Flynn LC, McCulloch PG, Morgan LJ, Robertson ER, New SJ, Stedman FE, Martin GP.

Ann Surg. 2016 Dec;264(6):997-1003.

PMID:
26704740
23.

Localized Epidermal Drug Delivery Induced by Supramolecular Solvent Structuring.

Benaouda F, Jones SA, Martin GP, Brown MB.

Mol Pharm. 2016 Jan 4;13(1):65-72. doi: 10.1021/acs.molpharmaceut.5b00499. Epub 2015 Dec 15.

PMID:
26593153
24.

Beyond metrics? Utilizing 'soft intelligence' for healthcare quality and safety.

Martin GP, McKee L, Dixon-Woods M.

Soc Sci Med. 2015 Oct;142:19-26. doi: 10.1016/j.socscimed.2015.07.027. Epub 2015 Jul 31.

25.

Professionalism Redundant, Reshaped, or Reinvigorated? Realizing the "Third Logic" in Contemporary Health Care.

Martin GP, Armstrong N, Aveling EL, Herbert G, Dixon-Woods M.

J Health Soc Behav. 2015 Sep;56(3):378-97. doi: 10.1177/0022146515596353. Epub 2015 Aug 14.

26.

The evolution of granule fracture strength as a function of impeller tip speed and granule size for a novel reverse-phase wet granulation process.

Wade JB, Martin GP, Long DF.

Int J Pharm. 2015 Jul 5;488(1-2):95-101. doi: 10.1016/j.ijpharm.2015.04.033. Epub 2015 Apr 15.

PMID:
25888799
28.

Controlling granule size through breakage in a novel reverse-phase wet granulation process: the effect of impeller speed and binder liquid viscosity.

Wade JB, Martin GP, Long DF.

Int J Pharm. 2015 Jan 30;478(2):439-46. doi: 10.1016/j.ijpharm.2014.11.067. Epub 2014 Dec 2.

PMID:
25475017
29.

Formulation pre-screening of inhalation powders using computational atom-atom systematic search method.

Ramachandran V, Murnane D, Hammond RB, Pickering J, Roberts KJ, Soufian M, Forbes B, Jaffari S, Martin GP, Collins E, Pencheva K.

Mol Pharm. 2015 Jan 5;12(1):18-33. doi: 10.1021/mp500335w. Epub 2014 Nov 24.

30.

Running a hospital patient safety campaign: a qualitative study.

Ozieranski P, Robins V, Minion J, Willars J, Wright J, Weaver S, Martin GP, Woods MD.

J Health Organ Manag. 2014;28(4):562-75.

31.

Feasibility assessment for a novel reverse-phase wet granulation process: the effect of liquid saturation and binder liquid viscosity.

Wade JB, Martin GP, Long DF.

Int J Pharm. 2014 Nov 20;475(1-2):450-61. doi: 10.1016/j.ijpharm.2014.09.012. Epub 2014 Sep 12.

PMID:
25218187
32.

Can we tell whether hospital care is safe?

Martin GP, Dixon-Woods M.

Br J Hosp Med (Lond). 2014 Sep;75(9):484-5. doi: 10.12968/hmed.2014.75.9.484. No abstract available.

PMID:
25216161
33.

After Mid Staffordshire: from acknowledgement, through learning, to improvement.

Martin GP, Dixon-Woods M.

BMJ Qual Saf. 2014 Sep;23(9):706-8. doi: 10.1136/bmjqs-2014-003359. Epub 2014 Jul 18. No abstract available.

PMID:
25038039
35.

Mission, margin, and the role of consumer governance in decision-making at community health centers.

Wright B, Martin GP.

J Health Care Poor Underserved. 2014 May;25(2):930-47. doi: 10.1353/hpu.2014.0107.

36.

Stability of sugar solutions: a novel study of the epimerization kinetics of lactose in water.

Jawad R, Drake AF, Elleman C, Martin GP, Warren FJ, Perston BB, Ellis PR, Hassoun MA, Royall PG.

Mol Pharm. 2014 Jul 7;11(7):2224-38. doi: 10.1021/mp400509t. Epub 2014 Jun 3.

PMID:
24815988
37.

Between surveillance and subjectification: professionals and the governance of quality and patient safety in English hospitals.

Martin GP, Leslie M, Minion J, Willars J, Dixon-Woods M.

Soc Sci Med. 2013 Dec;99:80-8. doi: 10.1016/j.socscimed.2013.10.018. Epub 2013 Oct 30.

PMID:
24355474
38.

An assessment of powder pycnometry as a means of determining granule porosity.

Wade JB, Martin GP, Long DF.

Pharm Dev Technol. 2015 May;20(3):257-65. doi: 10.3109/10837450.2013.860550. Epub 2013 Nov 26.

PMID:
24279883
39.

Improving quality and safety of care using "technovigilance": an ethnographic case study of secondary use of data from an electronic prescribing and decision support system.

Dixon-Woods M, Redwood S, Leslie M, Minion J, Martin GP, Coleman JJ.

Milbank Q. 2013 Sep;91(3):424-54. doi: 10.1111/1468-0009.12021.

40.

Frameworks for change in healthcare organisations: a formative evaluation of the NHS Change Model.

Martin GP, Sutton E, Willars J, Dixon-Woods M.

Health Serv Manage Res. 2013 Aug;26(2-3):65-75. doi: 10.1177/0951484813511233.

PMID:
25595003
41.
42.

Innovation sustainability in challenging health-care contexts: embedding clinically led change in routine practice.

Martin GP, Weaver S, Currie G, Finn R, McDonald R.

Health Serv Manage Res. 2012 Nov;25(4):190-9. doi: 10.1177/0951484812474246.

43.

Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction.

Jaffari S, Forbes B, Collins E, Barlow DJ, Martin GP, Murnane D.

Int J Pharm. 2013 Apr 15;447(1-2):124-31. doi: 10.1016/j.ijpharm.2013.02.034. Epub 2013 Feb 19.

44.

Leading from the middle: Constrained realities of clinical leadership in healthcare organizations.

Martin GP, Waring J.

Health (London). 2013 Jul;17(4):358-74. doi: 10.1177/1363459312460704. Epub 2012 Oct 11.

PMID:
23060359
45.

The influence of self-assembling supramolecular structures on the passive membrane transport of ion-paired molecules.

Benaouda F, Brown MB, Shah B, Martin GP, Jones SA.

Int J Pharm. 2012 Dec 15;439(1-2):334-41. doi: 10.1016/j.ijpharm.2012.09.001. Epub 2012 Sep 7.

PMID:
22982163
46.

Triggered in situ drug supersaturation and hydrophilic matrix self-assembly.

Benaouda F, Brown MB, Martin GP, Jones SA.

Pharm Res. 2012 Dec;29(12):3434-42. doi: 10.1007/s11095-012-0838-x. Epub 2012 Aug 30.

PMID:
22933015
47.

Discriminating the molecular identity and function of discrete supramolecular structures in topical pharmaceutical formulations.

Benaouda F, Brown MB, Ganguly S, Jones SA, Martin GP.

Mol Pharm. 2012 Sep 4;9(9):2505-12. doi: 10.1021/mp300127f. Epub 2012 Aug 2.

PMID:
22784303
48.

Citizens, publics, others and their role in participatory processes: a commentary on Lehoux, Daudelin and Abelson.

Martin GP.

Soc Sci Med. 2012 Jun;74(12):1851-3; discussion 1854-5. doi: 10.1016/j.socscimed.2012.02.030. Epub 2012 Mar 20. No abstract available.

PMID:
22503560
49.

The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.

Kaialy W, Larhrib H, Martin GP, Nokhodchi A.

Pharm Res. 2012 Aug;29(8):2139-56. doi: 10.1007/s11095-012-0743-3. Epub 2012 Apr 5.

PMID:
22477070
50.

Critical characteristics for corticosteroid solution metered dose inhaler bioequivalence.

Grainger CI, Saunders M, Buttini F, Telford R, Merolla LL, Martin GP, Jones SA, Forbes B.

Mol Pharm. 2012 Mar 5;9(3):563-9. doi: 10.1021/mp200415g. Epub 2012 Feb 10.

PMID:
22229274

Supplemental Content

Loading ...
Support Center